Heart Rate Variability Change After Liver Transplantation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00778687
First received: October 22, 2008
Last updated: December 22, 2013
Last verified: December 2013

October 22, 2008
December 22, 2013
October 2008
January 2010   (final data collection date for primary outcome measure)
Multiscale entropy [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Multiscale entropy was measured at nine time points: 1. preoperative, 2. postoperative day 1, 3. postoperative day 2, 4. postoperative day 3, 5. postoperative day 4, 6. postoperative day 7, 7. postoperative day 14, 8. postoperative 3 months, 9. postoperative 6 months
Not Provided
Complete list of historical versions of study NCT00778687 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Heart Rate Variability Change After Liver Transplantation
Effects of Liver Transplantation on the Heart Rate Variability in Patients With End-Stage Liver Disease

Cirrhotic cardiomyopathy describes a hyperdynamic state with the presentation of high cardiac output and low systemic vascular resistance. And the latent heart failure becomes obvious under physiologic and pharmacologic stress. The goal of our study is to assess the effects of liver transplantation on the heart rate variability in patients with end stage liver disease.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients with end stage liver disease undergoing liver transplantation

Liver Transplantation
Not Provided
Not Provided
Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Pieruzzi F, Vincenti A, Stella A, Mancia G, Stramba-Badiale M. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium. Clin Sci (Lond). 2009 May 14;116(12):851-9. doi: 10.1042/CS20080325.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
January 2010
January 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age:18-70y/o receiving liver transplantation

Exclusion Criteria:

  • History of cardiovascular disease
Both
18 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT00778687
200809046R
No
National Taiwan University Hospital
National Taiwan University Hospital
Not Provided
Not Provided
National Taiwan University Hospital
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP